Impact of Reduced Tigecycline Susceptibility on Clinical Outcomes of Acinetobacter Bacteremia

Publication date: Available online 7 October 2017 Source:Journal of Microbiology, Immunology and Infection Author(s): Yea-Yuan Chang, Yuag-Meng Liu, Chang-Pan Liu, Shu-Chen Kuo, Te-Li Chen The higher 14-day mortality rate for patients with Acinetobacter bacteremia receiving tigecycline appropriately compared to other appropriate antibiotics (36.4% versus 14.2%, P=0.028) was due to the poor effect of tigecycline for isolates with a minimum inhibitory concentration of 2 μg/mL (63.6% of 11 versus 14.2% of 127, P=0.001).
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research